Park Jeong-Ik, Kim Daehwan, Kim Hyangkyoung, Yang Seung Boo, Park Sang Jun, Kwon Young-Joo
Department of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Republic of Korea.
The Better-Way Clinic, Seoul 04715, Republic of Korea.
J Clin Med. 2025 Apr 29;14(9):3074. doi: 10.3390/jcm14093074.
: Socioeconomic status (SES) disparities impact health outcomes, but their effect on vascular access (VA) in hemodialysis patients in Korea remains underexplored. : This study evaluated the association between SES and VA outcomes using National Health Insurance Service data from 2008 to 2019. Incident hemodialysis patients were categorized by insurance status into the health insurance group (HG) and medical aid group (MG). The primary endpoint was VA patency, and the secondary endpoint was all-cause mortality, adjusted for demographics, comorbidities, and lifestyle factors. : Among 86,036 patients, the MG (12.1%) was younger at VA creation (60.4 ± 13.5 vs. 63.1 ± 13.6 years, < 0.001) and had higher rates of comorbidities (all < 0.05 except cancer). Mortality rates per 100 person-years were higher in the MG (11.66 vs. 9.24 for AVF; 17.94 vs. 16.92 for AVG), as was the total procedure frequency (2.10 vs. 1.87, < 0.001), despite similar percutaneous angioplasty counts (1.20 vs. 1.24, = 0.314). : Lower SES patients exhibited poorer VA patency and higher mortality rates despite equitable healthcare access and cost coverage in Korea. These findings suggest that non-medical factors, such as adherence to treatment and timely intervention, play a critical role in mitigating these disparities.
社会经济地位(SES)差异会影响健康结果,但在韩国,其对血液透析患者血管通路(VA)的影响仍未得到充分研究。本研究利用2008年至2019年的国民健康保险服务数据评估了SES与VA结果之间的关联。新发病的血液透析患者根据保险状况被分为健康保险组(HG)和医疗救助组(MG)。主要终点是VA通畅率,次要终点是全因死亡率,并对人口统计学、合并症和生活方式因素进行了调整。在86036名患者中,MG组(12.1%)在建立VA时年龄较小(60.4±13.5岁对63.1±13.6岁,P<0.001),合并症发生率较高(除癌症外,所有P<0.05)。MG组每100人年的死亡率较高(动静脉内瘘为11.66对9.24;动静脉移植物为17.94对16.92),总手术频率也较高(2.10对1.87,P<0.001),尽管经皮血管成形术的次数相似(1.20对1.24,P = 0.314)。尽管韩国的医疗保健可及性和费用覆盖公平,但社会经济地位较低的患者VA通畅率较差,死亡率较高。这些发现表明,诸如坚持治疗和及时干预等非医疗因素在减轻这些差异方面起着关键作用。